These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
275 related articles for article (PubMed ID: 36089157)
1. Blood-based biomarkers for hepatocellular carcinoma screening: Approaching the end of the ultrasound era? Parikh ND; Tayob N; Singal AG J Hepatol; 2023 Jan; 78(1):207-216. PubMed ID: 36089157 [TBL] [Abstract][Full Text] [Related]
2. A multivariate parametric empirical Bayes screening approach for early detection of hepatocellular carcinoma using multiple longitudinal biomarkers. Tayob N; Lok ASF; Feng Z Stat Med; 2022 Jun; 41(13):2338-2353. PubMed ID: 35199349 [TBL] [Abstract][Full Text] [Related]
3. Validation of a Novel Multitarget Blood Test Shows High Sensitivity to Detect Early Stage Hepatocellular Carcinoma. Chalasani NP; Porter K; Bhattacharya A; Book AJ; Neis BM; Xiong KM; Ramasubramanian TS; Edwards DK; Chen I; Johnson S; Roberts LR; Kisiel JB; Reddy KR; Singal AG; Olson MC; Bruinsma JJ Clin Gastroenterol Hepatol; 2022 Jan; 20(1):173-182.e7. PubMed ID: 34391922 [TBL] [Abstract][Full Text] [Related]
4. Surveillance and treatment of primary hepatocellular carcinoma (aka. STOP HCC): protocol for a prospective cohort study of high-risk patients for HCC using GALAD-score. Truong TN; Pham TND; Hoang LB; Nguyen VT; Dao HV; Dao DVB; Alessy S; Pham HB; Pham TTT; Nguyen LDD; Nguyen K; Abaalkhail F; Manal M; Mawardi M; AlZahrani M; Alswat K; Alghamdi H; Sanai FM; Siddiqui MA; Nguyen NH; Vaidya D; Phan HT; Johnson PJ; Alqahtani SA; Dao DY BMC Cancer; 2023 Sep; 23(1):875. PubMed ID: 37723439 [TBL] [Abstract][Full Text] [Related]
5. Surveillance Imaging and Alpha Fetoprotein for Early Detection of Hepatocellular Carcinoma in Patients With Cirrhosis: A Meta-analysis. Tzartzeva K; Obi J; Rich NE; Parikh ND; Marrero JA; Yopp A; Waljee AK; Singal AG Gastroenterology; 2018 May; 154(6):1706-1718.e1. PubMed ID: 29425931 [TBL] [Abstract][Full Text] [Related]
6. Biomarkers for the Early Detection of Hepatocellular Carcinoma. Parikh ND; Mehta AS; Singal AG; Block T; Marrero JA; Lok AS Cancer Epidemiol Biomarkers Prev; 2020 Dec; 29(12):2495-2503. PubMed ID: 32238405 [TBL] [Abstract][Full Text] [Related]
7. Advancing Surveillance Strategies for Hepatocellular Carcinoma: A New Era of Efficacy and Precision. Singal AG; Ng M; Kulkarni A J Clin Exp Hepatol; 2024; 14(6):101448. PubMed ID: 38946864 [TBL] [Abstract][Full Text] [Related]
8. Early detection of hepatocellular carcinoma: roadmap for improvement. Melendez-Torres J; Singal AG Expert Rev Anticancer Ther; 2022 Jun; 22(6):621-632. PubMed ID: 35514249 [TBL] [Abstract][Full Text] [Related]
9. Plasma cell free DNA methylation markers for hepatocellular carcinoma surveillance in patients with cirrhosis: a case control study. Lewin J; Kottwitz D; Aoyama J; deVos T; Garces J; Hasinger O; Kasielke S; Knaust F; Rathi P; Rausch S; Weiss G; Zipprich A; Mena E; Fong TL BMC Gastroenterol; 2021 Mar; 21(1):136. PubMed ID: 33765926 [TBL] [Abstract][Full Text] [Related]
10. Effectiveness of HCC surveillance programs using multitarget blood test: A modeling study. Chhatwal J; Samur S; Yang JD; Roberts LR; Nguyen MH; Ozbay AB; Ayer T; Parikh ND; Singal AG Hepatol Commun; 2023 Jun; 7(6):. PubMed ID: 37204402 [TBL] [Abstract][Full Text] [Related]
11. Evaluating screening approaches for hepatocellular carcinoma in a cohort of HCV related cirrhosis patients from the Veteran's Affairs Health Care System. Tayob N; Richardson P; White DL; Yu X; Davila JA; Kanwal F; Feng Z; El-Serag HB BMC Med Res Methodol; 2018 Jan; 18(1):1. PubMed ID: 29301497 [TBL] [Abstract][Full Text] [Related]
12. Comprehensive evaluation of microRNA as a biomarker for the diagnosis of hepatocellular carcinoma. Malik J; Klammer M; Rolny V; Chan HL; Piratvisuth T; Tanwandee T; Thongsawat S; Sukeepaisarnjaroen W; Esteban JI; Bes M; Köhler B; Swiatek-de Lange M World J Gastroenterol; 2022 Aug; 28(29):3917-3933. PubMed ID: 36157551 [TBL] [Abstract][Full Text] [Related]
13. Validation of the Updated Hepatocellular Carcinoma Early Detection Screening Algorithm in a Community-Based Cohort of Patients With Cirrhosis of Multiple Etiologies. Tayob N; Corley DA; Christie I; Almers L; Rahal AK; Richardson P; White DL; Davila J; Kanwal F; El-Serag HB Clin Gastroenterol Hepatol; 2021 Jul; 19(7):1443-1450.e6. PubMed ID: 32768590 [TBL] [Abstract][Full Text] [Related]
14. GALAD demonstrates high sensitivity for HCC surveillance in a cohort of patients with cirrhosis. Singal AG; Tayob N; Mehta A; Marrero JA; El-Serag H; Jin Q; Saenz de Viteri C; Fobar A; Parikh ND Hepatology; 2022 Mar; 75(3):541-549. PubMed ID: 34618932 [TBL] [Abstract][Full Text] [Related]
15. Multimarker Panels for Detection of Early Stage Hepatocellular Carcinoma: A Prospective, Multicenter, Case-Control Study. Piratvisuth T; Tanwandee T; Thongsawat S; Sukeepaisarnjaroen W; Esteban JI; Bes M; Köhler B; He Y; Swiatek-de Lange M; Morgenstern D; Chan HL Hepatol Commun; 2022 Apr; 6(4):679-691. PubMed ID: 34796691 [TBL] [Abstract][Full Text] [Related]